1Intody Z, Perkins BD, Wilson JH. Triple helix: a new promise for gene therapy. Orv Hetil,2003, 144: 757-763.
2Scaggiante B, Morassutti C, Tolazzi G, et al. Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdrl in MDR cancer cells. FEBS Lett, 1994, 352:380-384.
3Shen C, Buck A, Polat B, et al. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther, 2003,10: 403-410.
4Ryan K, Kool ET. Triplex-directed self-assembly of an artificial sliding clamp on duplexDNA. Chem Biol, 1998, 5: 59-67.
5Re RN, Cook JL, Giardina JF. The inhibition of tumor growth by triplex-forming oligonucleotides. Cancer Lett, 2004, 209: 51-53.
6Kassis AI, Aselstein SJ, Mariani G. Radiolabeled nucleoside analogs in cancer diagnosis and therapy. J Nucl Med, 1996, 40: 301-309.
7Sedelnikova OA, Panyutin IG, Luu AN, et al.The stability of DNA triplexes inside cells asstudied by 1251 radioprinting. Nucleic Acids Res, 1999, 27: 3844-3850.
8Sedelnikova OA, Panyutin IG, Luu AN, et al. Targeting the human mdrl gene by 125I labeled triplex-forming oligonucleotides. Antisense Nucleic Acid Drug Dev, 2000, 10: 443-452.
9Karamychev VN, Rsed MW, neumann RD, et al. Distribution of DNA strand breaks produced by 123I and [1]In in synthetic oligodeoxynucleotides. Acta Oncol, 2000, 39: 687-692.
10Shen CX, Rattat D, Buck A, et al. Targeting bcl-2 by triplex-forming oligonucleotide-a promising carrier for gene-radiotherapy. Can Bioth Radiopha, 2003, 18: 17-26.
